Glucaric acid

Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Glucaric acid?

Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Glucaric acid

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Lung Neoplasms D008175 171 associated lipids
Adenocarcinoma D000230 166 associated lipids
Edema D004487 152 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hemolysis D006461 131 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Inflammation D007249 119 associated lipids
Insulin Resistance D007333 99 associated lipids
Brain Ischemia D002545 89 associated lipids
Atherosclerosis D050197 85 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Hyperlipidemias D006949 73 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Parkinson Disease D010300 53 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Precancerous Conditions D011230 48 associated lipids
Leukemia P388 D007941 43 associated lipids
Occupational Diseases D009784 42 associated lipids
Hypotension D007022 41 associated lipids
Adenoma D000236 40 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Heart Failure D006333 36 associated lipids
Epilepsy D004827 35 associated lipids
Hyperplasia D006965 34 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Micronuclei, Chromosome-Defective D048629 33 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Liver Diseases D008107 31 associated lipids
Kidney Diseases D007674 29 associated lipids
Kidney Neoplasms D007680 29 associated lipids
Hyperinsulinism D006946 27 associated lipids
Alcoholism D000437 27 associated lipids
Myocardial Infarction D009203 21 associated lipids
Anemia D000740 21 associated lipids
Esophageal Neoplasms D004938 20 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Heart Defects, Congenital D006330 20 associated lipids
Myocardial Reperfusion Injury D015428 20 associated lipids
Tuberculosis, Pulmonary D014397 18 associated lipids
Peritoneal Neoplasms D010534 16 associated lipids
Vitamin D Deficiency D014808 13 associated lipids
Critical Illness D016638 13 associated lipids
Liver Diseases, Alcoholic D008108 13 associated lipids
Hypercalcemia D006934 13 associated lipids
Carbon Tetrachloride Poisoning D002252 12 associated lipids
Hypocalcemia D006996 12 associated lipids
Iron Overload D019190 11 associated lipids
Per page 10 20 50 100 | Total 85

PubChem Associated disorders and diseases

What pathways are associated with Glucaric acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Glucaric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Glucaric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Glucaric acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with Glucaric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Glucaric acid?

Knock-out

Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Glucaric acid

Download all related citations
Per page 10 20 50 100 | Total 1061
Authors Title Published Journal PubMed Link
Furuno K et al. Preventive effect of D-glucarate against renal damage induced by kanamycin. 1976 J. Antibiot. pmid:993134
Latham AN et al. Phenobarbitone-induced urinary excretions of D-glucaric acid and 6beta-hydroxycortisol in man. 1976 Can. J. Physiol. Pharmacol. pmid:991005
Roberts C et al. Glutethimide and enzyme induction. 1976 Br Med J pmid:990872
Edelson SB and Cantor DS Autism: xenobiotic influences. 1998 Nov-Dec Toxicol Ind Health pmid:9891912
Sato K and Shiraki M Saccharated ferric oxide-induced osteomalacia in Japan: iron-induced osteopathy due to nephropathy. 1998 Endocr. J. pmid:9881891
Hong SK and Rankin GO Biotransformation of 2-chloroaniline in the Fischer 344 rat: identification of urinary metabolites. 1998 Xenobiotica pmid:9849645
Kuramitsu Y et al. ND-2001 suppresses lung metastasis of human renal cancer cells in athymic mice. 1998 Anticancer Drugs pmid:9823433
Nonaka D et al. Gelatinous bone marrow transformation complicated by self-induced malnutrition. 1998 Acta Haematol. pmid:9792939
pmid:9775031
Hubbard BK et al. Evolution of enzymatic activities in the enolase superfamily: characterization of the (D)-glucarate/galactarate catabolic pathway in Escherichia coli. 1998 Biochemistry pmid:9772162
Sorrell MF et al. Paradoxical urinary excretion of D-glucaric acid in acute viral hepatitis. 1976 Clin. Pharmacol. Ther. pmid:954355
Kuramitsu Y et al. A new anti-metastatic drug, ND-2001, inhibits lung metastases in rat hepatoma cells by suppressing haptotaxis of tumor cells toward laminin. 1998 Anticancer Drugs pmid:9491797
al-Hawas F et al. Use of i.v. iron saccharate in haemodialysis patients not responding to oral iron and erythropoietin. 1997 Nephrol. Dial. Transplant. pmid:9430909
Sandle LN et al. Indirect evidence for hepatic induction in patients with cholesterol gallstones. 1997 Biochem. Soc. Trans. pmid:9388642
Cazzola M Recombinant human erythropoietin to assist autologous blood donation by patients with anemia. 1997 J. Lab. Clin. Med. pmid:9358072
Sunder-Plassmann G and Hörl WH Safety aspects of parenteral iron in patients with end-stage renal disease. 1997 Drug Saf pmid:9352960
Furuno K et al. Effect of D-Glucarates on basic antibiotic-induced renal damage in rats. 1976 J. Antibiot. pmid:931801
Cynke E [Parenteral iron replacement]. 1997 Praxis (Bern 1994) pmid:9312810
Hildebrandt AG et al. Evaluation of in vivo parameters of drug metabolizing enzyme activity in man after administration of clemastine, phenobarbital or placebo. 1975 Eur. J. Clin. Pharmacol. pmid:9297
pmid:9278881
Khaw BA et al. Avidity of technetium 99m glucarate for the necrotic myocardium: in vivo and in vitro assessment. 1997 Jul-Aug J Nucl Cardiol pmid:9278874
Beanlands RS et al. Differentiation of myocardial ischemia and necrosis by technetium 99m glucaric acid kinetics. 1997 Jul-Aug J Nucl Cardiol pmid:9278873
Sunder-Plassmann G et al. The dilemma of evaluating iron status in dialysis patients--limitations of available diagnostic procedures. 1997 Nephrol. Dial. Transplant. pmid:9269632
Miguel JC et al. Effects of iron salts in sucrose on dental caries and plaque in rats. 1997 Arch. Oral Biol. pmid:9233847
Narula J et al. Noninvasive detection of atherosclerotic lesions by 99mTc-based immunoscintigraphic targeting of proliferating smooth muscle cells. 1997 Chest pmid:9187194
Scassellati-Sforzolini G et al. In vivo studies on genotoxicity of pure and commercial linuron. 1997 Mutat. Res. pmid:9186570
Brunelle FM and Verbeeck RK Conjugation-deconjugation cycling of diflunisal via beta-glucuronidase catalyzed hydrolysis of its acyl glucuronide in the rat. 1997 Life Sci. pmid:9180355
Furuno K et al. Influence of dehydration and D-glucarate on distribution and excretion of kanamycin in rats. 1977 Jpn. J. Pharmacol. pmid:916384
Narula J et al. Very early noninvasive detection of acute experimental nonreperfused myocardial infarction with 99mTc-labeled glucarate. 1997 Circulation pmid:9118528
Petrov AD et al. Targeting human breast tumour in xeno-grafted SCID mice with 99Tcm-glucarate. 1997 Nucl Med Commun pmid:9106778
Walaszek Z et al. Metabolism, uptake, and excretion of a D-glucaric acid salt and its potential use in cancer prevention. 1997 Cancer Detect. Prev. pmid:9101079
Drzewiecki J Excretion of D-glucaric acid and metabolism of salicylamide in man: the effect of phenobarbital-produced enzymatic induction. 1977 Jul-Aug Pol J Pharmacol Pharm pmid:905203
Roth B et al. [Excretion of D-glucaric-acid in newborns with non-hemolytic hyperbilirubinemia after phenobarbital treatment (author's transl)]. 1977 Padiatr Padol pmid:904946
Rost KL et al. Urinary 6 beta-hydroxycortisol and D-glucaric acid excretion rates are not affected by lansoprazole treatment. 1997 Int J Clin Pharmacol Ther pmid:9021436
Bisio S and Franco G Drinking habits and occupational exposure to xenobiotics: a review. 1995 Jan-Nov G Ital Med Lav pmid:8940655
Sunder-Plassmann G and Hörl WH Safety of intravenous injection of iron saccharate in haemodialysis patients. 1996 Nephrol. Dial. Transplant. pmid:8918625
pmid:8902444
Talafant E et al. Negative feedback control of neonatal serum creatine and increased urinary creatinine excretion after enzyme-inducing drugs. 1977 Pediatr. Res. pmid:887306
Brunelle FM and Verbeeck RK Glucuronidation of diflunisal in liver and kidney microsomes of rat and man. 1996 Xenobiotica pmid:8867997
Lorincz M et al. Enzyme-generated intracellular fluorescence for single-cell reporter gene analysis utilizing Escherichia coli beta-glucuronidase. 1996 Cytometry pmid:8866216
Silverberg DS et al. Intravenous ferric saccharate as an iron supplement in dialysis patients. 1996 Nephron pmid:8852489
Monarca S et al. Biological monitoring of workers exposed to N-nitrosodiethanolamine in the metal industry. 1996 Environ. Health Perspect. pmid:8834865
Kawasaki H et al. Effect of corticosteroid treatment on bilirubin metabolism in chronic aggressive hepatitis. 1977 Acta Hepatogastroenterol (Stuttg) pmid:883466
Moretti M et al. Biological monitoring of genotoxic hazard in workers of the rubber industry. 1996 Environ. Health Perspect. pmid:8781380
Addyman R et al. Urinary glucaric acid excretion in rheumatoid arthritis: influence of disease activity and disease modifying drugs. 1996 Ann. Rheum. Dis. pmid:8774168
Fujihira E and Whitehouse MW Pathobiodynamics: reduced ascorbate excretion by rats with severe inflammation. 1977 Proc. Soc. Exp. Biol. Med. pmid:877135
Meyer MP et al. A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin. 1996 J. Pediatr. pmid:8765624
Sung RY et al. Urinary D-glucaric acid excretion in idiopathic neonatal jaundice. 1996 Chin. Med. J. pmid:8758309
Tryba M Epoetin alfa plus autologous blood donation in patients with a low hematocrit scheduled to undergo orthopedic surgery. 1996 Semin. Hematol. pmid:8723577
Mercuriali F Epoetin alfa for autologous blood donation in patients with rheumatoid arthritis and concomitant anemia. 1996 Semin. Hematol. pmid:8723576
Mercuriali F Epoetin alfa increases the volume of autologous blood donated by patients scheduled to undergo orthopedic surgery. 1996 Semin. Hematol. pmid:8723574
Collinot JP et al. Evaluation of urinary D-glucaric acid excretion in workers exposed to butyl glycol. 1996 J Toxicol Environ Health pmid:8691506
Cassimos C et al. Erythrocyte glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice. 1977 Acta Paediatr Scand pmid:868519
Silverberg DS et al. Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis. 1996 Am. J. Kidney Dis. pmid:8659499
Meier JR et al. Urine mutagenicity and biochemical effects of the drinking water mutagen, 3-chloro-4-(dichloromethyl)-5-hydroxy-2[5H]-furanone (MX), following repeated oral administration to mice and rats. 1996 Toxicology pmid:8658560
Weiersmüller A et al. The influence of prednisolone on hepatic function in normal subjects. Effects on galactose elimination capacity, sulfobromophthalein transport maximum and storage capacity, and D-glucaric acid output. 1977 Am J Dig Dis pmid:857663
Tsuruoka T et al. Inhibition of tumor cell haptotaxis by sodium D-glucaro-delta-lactam (ND2001). 1995 Jpn. J. Cancer Res. pmid:8567400
Abou-Issa H et al. Basis for the anti-tumor and chemopreventive activities of glucarate and the glucarate:retinoid combination. 1993 Mar-Apr Anticancer Res. pmid:8517653
Breimer DD et al. Influence of rifampicin on drug metabolism: differences between hexobarbital and antipyrine. 1977 Clin. Pharmacol. Ther. pmid:849678
Edwards JW and Priestly BG Sister chromatid exchanges in lymphocytes of petroleum retailers. 1993 Br J Ind Med pmid:8435347
Ohnhaus EE et al. Enzyme induction and renal function in man. 1977 Br J Clin Pharmacol pmid:843422
Ballinger JR et al. Effect of hypoxia on the accumulation of technetium-99m-glucarate and technetium-99m-gluconate by Chinese hamster ovary cells in vitro. 1993 J. Nucl. Med. pmid:8381475
Sandstad O et al. Urinary D-glucaric acid, a marker substance for microsomal enzyme induction. Methodological aspects, responses to alcohol and findings in workers exposed to toluene. 1993 Scand. J. Clin. Lab. Invest. pmid:8378735
Höchli P et al. Repeated continuous administration of low doses of intravenous iron in anemic patients with active rheumatoid arthritis. 1993 Eur. J. Haematol. pmid:8348948
Okuyama T et al. [Measurement and its fluctuation of urinary glucaric acid in newborns]. 1993 Nippon Sanka Fujinka Gakkai Zasshi pmid:8340644
Poon R et al. HPLC determination of D-glucaric acid in human urine. 1993 May-Jun J Anal Toxicol pmid:8336488
Notten WR and Henderson PT The interaction of chemical compounds with the functional state of the liver. II. Estimation of changes in D-glucaric acid synthesis as a method for diagnosing exposure to xenobiotics. 1977 Int Arch Occup Environ Health pmid:832915
Yaoita H et al. Distribution of deoxyglucose and technetium-99m-glucarate in the acutely ischemic myocardium. 1993 J. Nucl. Med. pmid:8326389
Suzuki A et al. Iatrogenic osteomalacia caused by intravenous administration of saccharated ferric oxide. 1993 Am. J. Hematol. pmid:8317471
Webb TE et al. Mechanism of growth inhibition of mammary carcinomas by glucarate and the glucarate: retinoid combination. 1993 Nov-Dec Anticancer Res. pmid:8297119
Brunelle FM and Verbeeck RK Glucuronidation of diflunisal by rat liver microsomes. Effect of microsomal beta-glucuronidase activity. 1993 Biochem. Pharmacol. pmid:8267644
Hoffmann D [Role of phagocytosis and soluble antibacterial factors in experimental immunization of Locusta migratoria]. 1976 C.R. Hebd. Seances Acad. Sci., Ser. D, Sci. Nat. pmid:821627
Marselos M Genetic variation of drug-metabolizing enzymes in the wistar rat. 1976 Acta Pharmacol Toxicol (Copenh) pmid:821309
Curley RW et al. Activity of D-glucarate analogues: synergistic antiproliferative effects with retinoid in cultured human mammary tumor cells appear to specifically require the D-glucarate structure. 1994 Life Sci. pmid:8190001
Webb TE et al. Pharmacokinetics relevant to the anti-carcinogenic and anti-tumor activities of glucarate and the synergistic combination of glucarate:retinoid in the rat. 1994 Biochem. Pharmacol. pmid:8185680
Newman MA et al. Urinary biological monitoring markers of anticancer drug exposure in oncology nurses. 1994 Am J Public Health pmid:8179062
Ferreira M et al. Determinants of urinary thioethers, D-glucaric acid and mutagenicity after exposure to polycyclic aromatic hydrocarbons assessed by air monitoring and measurement of 1-hydroxypyrene in urine: a cross-sectional study in workers of coke and graphite-electrode-producing plants. 1994 Int Arch Occup Environ Health pmid:8175189
Franco G and Fonte R Advances in evaluating liver response to operating theatre work: urinary D-glucaric acid as an index of effect. 1994 Occup Med (Lond) pmid:8167312
Marselos M and Laitinen M Starvation and phenobarbital treatment effects on drug hydroxylation and glucuronidation in the rat liver and small intestinal mucosa. 1975 Biochem. Pharmacol. pmid:811226
Marselos M et al. Aldehyde dehydrogenase inducibility and ethanol preference in rats. 1975 Med. Biol. pmid:810629
Sacco C et al. Selective inhibition of gastrointestinal beta-glucuronidase by polyvinylbenzyl D-glucaro(1,4)lactonate: attachment of D-glucaro(1,4)lactone to polyvinylbenzyl chloride. 1993 Hum Exp Toxicol pmid:8096720
Mizumoto Y et al. [Measurement and fluctuation of urinary glucaric acid in pregnant women]. 1994 Nippon Sanka Fujinka Gakkai Zasshi pmid:8089594
Fujimoto T et al. A new clinical prognostic predictor for patients with biliary atresia. 1994 J. Pediatr. Surg. pmid:8078014
Malaka-Zafiriu K et al. D-Glucaric acid excretion in newborns with severe jaundice of unknown etiology and due to glucose-6-phosphate dehydrogenase deficiency in Greece. 1975 Helv Paediatr Acta pmid:807541
Previs SF et al. Use of [6,6-2H2]glucose and of low-enrichment [U-13C6]-glucose for sequential or simultaneous measurements of glucose turnover by gas chromatography-mass spectrometry. 1994 Anal. Biochem. pmid:8053553
Ciuffi M et al. Effect of 21-aminosteroid U74500A (pregna-1,4,9(11)-triene-3,20-dione, 21-(4-(5,6-bis(diethylamino)-2-pyridinyl)-1-piperazinyl)-16-methyl-, HCl (16 alpha)) on rat brain cortex lipid peroxidation induced "in vivo" by iron-carbohydrate. 1994 Biochem. Pharmacol. pmid:8031311
Hanaue H et al. Estimation of the functional reserve of the human liver by urinary D-glucaric acid excretion after vitamin C administration. 1993 Tokai J. Exp. Clin. Med. pmid:7940601
Tokola O et al. Hepatic drug-oxidizing enzyme systems and urinary D-glucaric acid excretion in patients with congestive heart failure. 1975 Br J Clin Pharmacol pmid:786355
Sacco C and Calabrese EJ Selective inhibition of gastrointestinal beta-glucuronidase by poly(vinylbenzyl D-glucaro(1,4)lactonate). Part 2. Poly(vinylbenzyl D-glucaro(1,4) lactonate) in vitro inhibition studies. 1994 Hum Exp Toxicol pmid:7857695
Konjiki O et al. [A case of hypophosphatemia induced by intravenous administration of saccharated iron oxide]. 1994 Nihon Ronen Igakkai Zasshi pmid:7853746
Edwards JW and Priestly BG Effect of occupational exposure to aldrin on urinary D-glucaric acid, plasma dieldrin, and lymphocyte sister chromatid exchange. 1994 Int Arch Occup Environ Health pmid:7843832
Fuchs W et al. Lansoprazole does not affect the bioavailability of oral contraceptives. 1994 Br J Clin Pharmacol pmid:7833230
Nakamura T et al. A novel oligosaccharide, GlcA beta 1-4Xyl beta 1-(4-methylumbelliferone), synthesized by human cultured skin fibroblasts. 1994 Biochem. J. pmid:7818474
McLean AE Cancer and nutrition (review). 1976 Nahrung pmid:781541
Heerdt AS et al. Calcium glucarate as a chemopreventive agent in breast cancer. 1995 Feb-Mar Isr. J. Med. Sci. pmid:7744577
Tsuruoka T et al. Inhibition of pulmonary metastases and tumor cell invasion in experimental tumors by sodium D-glucaro-delta-lactam (ND2001). 1995 Jpn. J. Cancer Res. pmid:7737908
Wiśniewska-Knypl JM and Wrońska-Nofer T Biological markers of oxidative stress induced by ethanol and iron overload in rat. 1994 Int J Occup Med Environ Health pmid:7719662
Abou-Issa H et al. Relative efficacy of glucarate on the initiation and promotion phases of rat mammary carcinogenesis. 1995 May-Jun Anticancer Res. pmid:7645962
Ciaccio EI and Fruncillo RJ Urinary excretion of D-glucaric acid by severely burned patients. 1979 Clin. Pharmacol. Ther. pmid:761444
Reidenberg P et al. Effects of felbamate on the pharmacokinetics of phenobarbital. 1995 Clin. Pharmacol. Ther. pmid:7554701